Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-014-0649-z
PubMed Identifier: 25434816
Publication URI: http://europepmc.org/abstract/MED/25434816
Type: Journal Article/Review
Volume: 18
Parent Publication: Critical care (London, England)
Issue: 6
ISSN: 1364-8535